Streptomycin and Pyridomycin drug molecules provide the most potential inhibitors against Rv3871 to cure Tuberculosis
S. Bhushan, Y. S. Raja, S. Mishra
This paper identifies streptomycin and pyridomycin as potential inhibitors of Rv3871, an ATPase involved in ESAT-6/CFP-10 secretion in Mycobacterium tuberculosis, aiming to treat tuberculosis.
bioRxiv · Jul 19, 2022Microbiology